Table of Contents

 

 

 

 

Preface

xiii

1

Disease Screening

 

 

Abdominal Aortic Aneurysm

2

 

Alcohol Abuse & Dependence

3

 

Anemia

4

 

Atlention-Deficit/Hyperactivity Disorder

6

 

Bacteriuria, Asymptomatic

7

 

Bacterial Vaginosis

8

 

Barrett’s Esophagus

9

 

Cancer

 

 

Bladder

10

 

Breast

12

 

Cervical

19

 

Colorectal

23

 

Endometrial

28

 

Gastric

30

 

Liver

31

 

Lung

32

 

Oral

34

 

Ovarian

35

 

Pancreatic

37

 

Prostate

38

 

Skin

41

 

Testicular

42

 

Thyroid

43

 

Carotid Artery Stenosis

44

 

Celiac Disease

45

 

Chlamydia

46

 

Cholesterol & Lipid Disorders

47

 

Children

47

 

Adults

48

 

Coronary Artery Disease

50

 

Dementia

53

 

Depression

54

 

Developmental Dysplasia of the Hip

55

 

Diabetes Mellitus

 

 

Gestational

56

 

Type 2

57

 

Falls in the Elderly

59

 

Family Violence and Abuse

60

 

Gonorrhea

61

 

Group B Streptococcal Disease

62

 

Growth Abnormalities, Infant

63

 

Hearing Impairment

64

 

Hemochromatosis

65

 

Hemoglobinopathies

67

 

Hepatitis B Virus Infection, Chronic

68

 

Hepatitis C Virus Infection, Chronic

69

 

Herpes Simplex Virus, Genital

71

 

Human Immunodeficiency Virus

72

 

Hypertension

 

 

Children & Adolescents

74

 

Adults

75

 

Illicit Drug Use

77

 

Kidney Disease, Chronic

78

 

Lead Poisoning

79

 

Motor Vehicle Safety

81

 

Newborn screening

82

 

Obesity

83

 

Children

 

 

Adults

 

 

Osteoporosis

85

 

Phenylketonuria

86

 

RH (D) Incompatibility

87

 

Scoliosis

88

 

Speech & Language Delay

89

 

Syphilis

90

 

Thyroid Disease

91

 

Pregnancy and Postpartum

92

 

Tobacco Use

93

 

Tuerculosis, Latent

95

 

Visual Impairment, Glaucoma, or Cataract

96

2

Disease Prevention

 

 

Primary Prevention of Cancer: NCI Evidence Summary

98

 

Catheter-Related Bloodstream Infections

106

 

Dental Caries

107

 

Diabetes Mellitus, Type 2

108

 

Domestic Violence

109

 

Endocarditis

111

 

Falls in the Elderly

112

 

Gonorrhea, Ophthalmia Neonatorum

113

 

Group B Streptococcal Infection

114

 

Human Immunodeficiency Virus, Opportunistic Infections

115

 

Prevention Among HIV-Infected Adults

116

 

Prevention Among HIV-Exposed and HIV-Infected Infants and children

120

 

Hypertension

124

 

Lifestyle Modifications

125

 

Immunizations

 

 

Adults

126

 

Infants and Children

127

 

Children and Adolescents

128

 

Influenza

 

 

Chemoprophylaxis

129

 

Vaccination

130

 

Motor Vehicle Injury

131

 

Myocardial Infarction

132

 

Neural Tube Defects

139

 

Obesity

140

 

Osteoporotic Hip Fractures

141

 

Pressure Ulcers

142

 

Sexually Transmitted Infections

144

 

Stroke

145

 

Sudden Infant Death Syndrome

150

 

Tobacco Use

151

 

Venous Thromboembolism

152

 

Prophylaxis in Nonsurgical Patients

152

 

Surgical Patients

157

3

Disease Management

 

 

Adrenal Incidentalomas

162

 

Alcohol Use Disorders

163

 

Anaphylaxis

164

 

Androgen Deficiency Syndrome

165

 

Anxiety

166

 

Asthma

167

 

Atrial Fibrillation

 

 

Management

169

 

HAS-BLED Bleeding Risk Score for Warfarin Therapy

176

 

Thromboembolic Risk Scores in Nonvalvular Atrial Fibrillation

178

 

Risk Factors for Stroke and Thromboembolism in Nonvalvular AF

178

 

Attention-Deficit Hyperactivity Disorder

179

 

Autism

180

 

Barrett’s Esophagus

181

 

Benign Prostatic Hyperplasia

182

 

Bronchitis, Acute

184

 

CA Survivorship

185

 

Late Effects of CA Treatments

 

 

Carotid Artery Stenosis

190

 

Cataract in Adults

 

 

Evaluation & Management

191

 

Cerumen Impaction

193

 

Cholesterol & Lipid Management

 

 

Adults

194

 

Children

197

 

Colitis, Clostridium Difficile

198

 

Constipation

199

 

Contraception, Emergency

200

 

Contraceptive Use

 

 

Changes Classifications

201

 

Recommendations

208

 

Additional Changes

212

 

Chronic Obstructive Pulmonary Disease

 

 

COPD Exacerbations

213

 

Stable COPD

214

 

Coronary Artery Disease

 

 

Therapy Use of Triple Anticoagulation Treatment

216

 

Therapy for Unstable Angina

218

 

Delirium

219

 

Dementia

220

 

Alzheimer’s Disease

221

 

Depression

222

 

Diabetes Mellitus

 

 

Type 1

223

 

Type 2

225

 

Foot Problems, Inpatient Management

231

 

Erectile Dysfunction

232

 

Glaucoma, Chronic Open Angle

233

 

Headache

 

 

Migraine Prophylaxis

234

 

Hearing Loss, Sudden

243

 

Heart Failure

244

 

Heart Failure 2012

245

 

Hemochromatosis

247

 

Hepatitis B Virus

248

 

Hepatitis C Virus

249

 

Hoarseness

250

 

Human Immunodeficiency Virus Adults and Children

251

 

Antiretroviral Therapy

253

 

Antiretroviral Use

254

 

Pregnancy

255

 

Hypertension

 

 

Initiating Treatment

257

 

Lifestyle Modifications

258

 

Recommended Medications for Compelling Indications

259

 

Refractory Hypertension

259

 

Children and Adolescents

260

 

2012 Joint National Committee HTN

262

 

Hypogonadism, Male

263

 

Infertility, Male

264

 

Influenza

265

 

Kidney Disease

 

 

Chronic

266

 

Chronic-Mineral and Bone Disorders

268

 

Kidney Stones

269

 

Back Pain, Low

270

 

Evaluation and Management

271

 

Menopause

272

 

Metabolic Syndrome

 

 

Identification & Management

273

 

Methicillin-Resistant Staphylococcus Aureus

274

 

Febrile Neutropenia

276

 

Obesity Management

278

 

Osteoarthritis

280

 

Osteoporosis

 

 

Evaluation and Management

281

 

Glucocorticoid-Induced

284

 

Otitis Media, Acute

286

 

Palliative & End-of-Life Care

 

 

Pain Management

288

 

Abnormal Pap Smear

289

 

Perioperative Cardiovascular Evaluation

290

 

Approach to Pharyngitis, Acute

292

 

Pneumonia, Community-Acquired Evaluation

293

 

Suspected Pathogens

294

 

Pregnancy

 

 

Routine Prenatal Care

295

 

Perinatal & Postnatal Guidelines

298

 

Preterm Labor, Tocolysis

299

 

Psoriasis

 

 

Plaque-Type

300

 

Psoriatic Arthritis

301

 

Respiratory Tract Infections, Lower

303

 

Rheumatoid Arthritis

 

 

Biologic Disease-Modifying Antirheumatic Drugs

304

 

Nonbiologic Disease-Modifying Antirheumatic Drugs

305

 

Noninfectious Rhinitis Management

306

 

Seizures, Febrile

307

 

Sexually Transmitted Diseases

308

 

Syphilis

315

 

Management of Thyroid Nodules

316

 

Thyroid Disease

 

 

Hyperthyroidism

317

 

Pregnancy and Postpartum

319

 

Tobacco Cessation

320

 

Tonsillcctomy

323

 

Tremor, Essential

324

 

Tuberculosis, Multidrug-Resistant

325

 

Urinary Incontinence

 

 

Stress

326

 

Men

327

 

Women

328

 

Urinary Tract Infections (UTIs)

329

 

Lower Urinary Tract Symptoms (LUTS)

332

 

Venous Thromboembolism

 

 

Diagnosis and Treatment of Venous

 

 

Thromboembolism (VTE) Wells Criteria

333

 

Deep Vein Thrombosis (DVT)

334

 

Diagnosis of Deep Venous Thrombosis (DVT)

337

 

Pulmonary Embolus (PE)

338

 

Diagnosis of Pulmonary Embolism (PE)

339

 

New Oral Anticoagulants and Warfarin

340

 

Vertigo, Benign Paroxysmal Positional (BPPV)

341

4

APPENDICES

 

Appendix I

Screening Instruments

 

 

Alcohol Abuse

344

 

Depression

347

 

Geriatric Depression Scale

351

Appendix II

Functional Assessment Screening in the Elderly

352

Appendix III

Screening and Prevention Guidelines in Perspective

354

Appendix IV

95th Percenlilc of Blood Pressure

 

 

Boys

356

 

Girls

357

Appendix V

Body Mass Index Conversion Table

358

Appendix VI

Cardiac Risk—Farmingham Study

 

 

Men

359

 

Women

361

Appendix VII

Estimate of 10-Year Stroke Risk

 

 

Men

363

 

Women

364

Appendix VIII

Immunizations Schedules

366

Appendix IX

Professional Soeicties and Governmental Agencies

376

 

Index

379